These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
17. Xanthogranulomatous orchitis in a patient with a history of instrumentation and bacillus Calmette-Guérin therapy. Hill JR, Gorgon G, Wahl SJ, Armenakas NA, Fracchia JA. Urology; 2008 Aug; 72(2):461.e11-3. PubMed ID: 18336889 [Abstract] [Full Text] [Related]
18. [Diagnosis and management of adverse events occuring during BCG therapy for non-muscle invasive bladder cancer (NMIBC): review of the Cancer Committee of the French Association of Urology]. Neuzillet Y, Rouprêt M, Wallerand H, Pignot G, Larré S, Irani J, Davin JL, Moreau JL, Soulié M, Pfister C, le comité de cancérologie de l’association française d’urologie. Prog Urol; 2012 Dec; 22(16):989-98. PubMed ID: 23178094 [Abstract] [Full Text] [Related]
19. Ocular involvement following Bacillus Calmette-Guerin immunotherapy for bladder carcinoma. Cugati S, Gilhotra JS, Lake S, Gordon DL. Clin Exp Ophthalmol; 2014 Jul; 42(5):494-5. PubMed ID: 24372891 [No Abstract] [Full Text] [Related]
20. Small bladder and multiple urethral recurrences after intravesical instillation of bacillus Calmette-Guerin for superficial transitional cell carcinoma of the bladder. Manasia P, Alcaraz A, Cetina A, Alcover J. J Urol; 2001 Feb; 165(2):529-30. PubMed ID: 11176420 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]